Innovacell Inc.
Research Innovacell Inc. (504A.T) on Bullrun: market cap JPY 24.34B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker504A.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyJPY
- Market capJPY 24.34B
- Financial periodQ4 2025
- RevenueJPY 0
- Net income-JPY 760.53M
Valuation Snapshot
latest market cap is JPY 24.34B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 24.34B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 JPY.
About Innovacell Inc.
Innovacell Inc. develops, manufactures, and sells cell therapy and regenerative medicine products. The company's products include ICEF15, a cell treatment for urgent fecal incontinence; ICEF16, a cell therapy for leaky fecal incontinence; and ICES13, a cell therapy for stress urinary incontinence. Innovacell Inc. was incorporated in 2021 and is based in Shinagawa, Japan.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Innovacell Inc.'s market cap?
Innovacell Inc.'s market capitalization is JPY 24.34B.
What does Innovacell Inc. do?
Innovacell Inc. develops, manufactures, and sells cell therapy and regenerative medicine products. The company's products include ICEF15, a cell treatment for urgent fecal incontinence; ICEF16, a cell therapy for leaky fecal incontinence; and ICES13, a cell therapy for stress urinary incontinence. Innovacell Inc. was incorporated in 2021 and is based in Shinagawa, Japan.